Kestra Medical Technologies (KMTS) Income Statement (2024 - 2026)
Income Statement report data from Jul 31, 2024 to Jan 31, 2026 for Kestra Medical Technologies (KMTS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Jan 31, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | |
|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||
Total Revenue | 25M (+8.77%) | 23M (+16.52%) | 19M (+12.42%) | 17M (+14.18%) | 15M (+2.58%) | 15M (+15.10%) | 13M |
Gross Profit | 13M (+13.05%) | 11M (+29.04%) | 8.85M (+15.99%) | 7.63M (+16.49%) | 6.55M (+12.35%) | 5.83M (+38.81%) | 4.20M |
Operating Expenses | |||||||
Research And Development | 4.97M (+1.84%) | 4.88M (+22.00%) | 4.00M (-25.79%) | 5.39M (+60.90%) | 3.35M (-4.56%) | 3.51M (+3.24%) | 3.40M |
Selling General And Administrative | 43M (+11.49%) | 38M (+13.55%) | 34M (-33.15%) | 50M (+112.02%) | 24M (+10.90%) | 21M (+11.60%) | 19M |
Operating Expenses | 48M (+10.40%) | 43M (+14.44%) | 38M (-32.44%) | 56M (+105.71%) | 27M (+8.77%) | 25M (+10.30%) | 23M |
Depreciation And Amortization | 1.98M (-16.46%) | 2.37M (+16.75%) | 2.03M (+10.33%) | 1.84M (-2.65%) | 1.89M (+1.07%) | 1.87M (-21.43%) | 2.38M |
Operating Income | |||||||
Operating Income | -34.76M (+9.48%) | -31.75M (+9.94%) | -28.88M (-40.10%) | -48.21M (+134.03%) | -20.60M (+7.68%) | -19.13M (+3.80%) | -18.43M |
Ebit | -34.76M (+9.48%) | -31.75M (+9.94%) | -28.88M (-40.10%) | -48.21M (+134.03%) | -20.60M (+7.68%) | -19.13M (+3.80%) | -18.43M |
EBITDA | -32.78M (+11.57%) | -29.38M (+9.42%) | -26.85M (-42.11%) | -46.38M (+147.89%) | -18.71M (+8.40%) | -17.26M (+7.47%) | -16.06M |
Other Income / Expenses | |||||||
Interest Income | 2.16M (+20.00%) | 1.80M (-17.05%) | 2.17M (+30.72%) | 1.66M (+163.49%) | 630K (-28.41%) | 880K (+2100.00%) | 40K |
Interest Expense | 1.89M (-0.53%) | 1.90M (-0.52%) | 1.91M (+8.52%) | 1.76M (-1.12%) | 1.78M (-23.28%) | 2.32M (+24.06%) | 1.87M |
Net Interest Income | 2.16M (+20.00%) | 1.80M (-17.05%) | 2.17M (+30.72%) | 1.66M (+163.49%) | 630K (-28.41%) | 880K (+2100.00%) | 40K |
Other Non Operating Income | 360K | -890.00K | 2.83M | -2.77M | 20K | -40.00K (-20.00%) | -50.00K |
Net Income | |||||||
Income Before Tax | -34.13M (+4.21%) | -32.75M (+26.99%) | -25.79M (-49.44%) | -51.01M (+134.64%) | -21.74M (+5.48%) | -20.61M (+1.43%) | -20.32M |
Income Tax Expense | 40K (+33.33%) | 30K (0.00%) | 30K (-70.00%) | 100K (+400.00%) | 20K (+100.00%) | 10K (0.00%) | 10K |
Net Income From Continuing Operations | -34.17M (+4.24%) | -32.78M (+26.91%) | -25.83M (-50.37%) | -52.05M (+141.98%) | -21.51M (+5.60%) | -20.37M (+2.46%) | -19.88M |
Net Income | -34.17M (+4.24%) | -32.78M (+26.91%) | -25.83M (-50.37%) | -52.05M (+141.98%) | -21.51M (+5.60%) | -20.37M (+2.46%) | -19.88M |